Bill > HB334

This bill establishes an annual review process for sickle cell disease (SCD) treatments under Georgia's Medicaid program. Specifically, the Department of Community Health will be required to conduct a comprehensive annual review of all medications, treatments, and services available to Medicaid recipients with SCD, with the goal of determining whether the current coverage adequately meets patients' needs. As part of this process, the department must actively seek public input, particularly from individuals and groups with expertise in SCD treatment. By January 15th each year, the department must submit a detailed report to the Georgia General Assembly's presiding officers, including their findings and recommendations, and must also publish this report on their public website. The bill aims to ensure ongoing evaluation and potential improvement of SCD care for Medicaid recipients by creating a structured, transparent review mechanism that incorporates diverse perspectives and expertise.

Health and Social Services

https://www.legis.ga.gov/legislation/70064